Mimicking Bone Extracellular Matrix: From BMP-2-Derived Sequences to Osteogenic-Multifunctional Coatings

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Tissue Engineering

Background:

• Mimicking bone extracellular matrix (ECM) on biomaterials is key for cell-material interactions.
• Replicating extracellular conditions that promote integrin and growth factor (GF) signaling is crucial for bone regeneration.
• Synthetic osteogenic domains from bone morphogenetic protein 2 (BMP-2) offer a safer alternative to clinical GF use.

Purpose of the Study:

• To screen BMP-2 epitopes for osteogenic peptides.
• To create multifunctional peptides by combining BMP-2 derived sequences with RGD cell adhesive peptides.
• To functionalize titanium surfaces with these peptides and evaluate their osteogenic potential.

Main Methods:

• Screening of BMP-2 wrist and knuckle epitopes to identify active peptide sequences.
• Synthesis of peptides combining osteogenic (DWIVA) and cell-adhesive (RGD) motifs, including cyclic variants.
• Functionalization of titanium surfaces with the developed multifunctional peptides.
• In vitro studies using mesenchymal stem cells to assess cell adhesion and osteogenic differentiation.
• In vivo studies in rat calvarial defects to evaluate new bone formation and fibrous tissue thickness.

Main Results:

• Identification of the DWIVA motif and its cyclic version as active osteogenic sequences.
• Successful creation of tailor-made biomimetic peptides presenting bioactive cues in a defined manner.
• Demonstration of synergistic enhancement in cell adhesion and osteogenic differentiation on functionalized titanium surfaces.
• In vivo evidence of improved new bone formation and reduced fibrous tissue thickness in rat calvarial defects.

Conclusions:

• Synthetic peptides can effectively mimic integrin-GF signaling for bone regeneration.
• Biomimetic peptide coatings on titanium enhance bone formation without requiring exogenous growth factors.
• This strategy holds significant potential for developing advanced bone regenerative therapies.